1. Home
  2. Companies
  3. BioMarin Pharmaceutical
  4. Financial Ratios
  5. DSO Ratio
BioMarin Pharmaceutical logo
BioMarin Pharmaceutical BMRN
$ 50.2 0.78%

Quarterly report 2026-Q1
added 05-05-2026

report update icon

BioMarin Pharmaceutical DSO Ratio 2011-2026 | BMRN

Annual DSO Ratio BioMarin Pharmaceutical

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
88.9 82.8 82.6 72.7 81.2 81 80.8 83.9 72.6 70.4 73.5 97.8 78.4 79.5 91.7

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
97.8 70.4 81.2

Quarterly DSO Ratio BioMarin Pharmaceutical

2026-Q1 2025-Q4 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
108 - 88.2 85.7 - 89.9 85.1 89.4 - 92.8 92.6 81 - 37.9 36.8 70.6 - 89.2 74.6 79.3 - 85.8 95.3 75 - 74.7 88.8 82 - 79.8 83.9 73.8 - 71.4 75.1 71.6 - 70.2 65.5 73.3 - 72 60.2 69.6 - 74.7 68.7 79 - 78.5 78.6 80.9 - 77.7 80.2 83.7 - 84.3 86.5 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
108 36.8 78.2

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
 		2.94 K - 5743.5 % $ 69.7 M canadaCanada
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		29 - 1.35 % $ 17.8 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
 		186 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
 		271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		84.7 - - $ 40.3 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.75 K - -1.52 % $ 24.7 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
 		99.7 $ 3.13 - $ 651 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
 		39.1 $ 34.45 4.74 % $ 927 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		204 - -18.52 % $ 27.3 M britainBritain
Celyad Oncology SA Celyad Oncology SA
CYAD
 		64.4 - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
 		103 - -7.31 % $ 87 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
 		21.2 $ 6.82 1.94 % $ 187 M israelIsrael
Generation Bio Co. Generation Bio Co.
GBIO
 		47.6 - - $ 344 M usaUSA
IMV IMV
IMV
 		2.16 K - - $ 13.1 M canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		58.2 $ 1.62 -0.61 % $ 431 M britainBritain
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		61.7 - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		3.66 K - -4.36 % $ 27 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
 		400 $ 2.71 -0.92 % $ 253 M israelIsrael
Anika Therapeutics Anika Therapeutics
ANIK
 		76.5 $ 15.14 2.16 % $ 217 M usaUSA
Advaxis Advaxis
ADXS
 		3.28 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		146 - 5.93 % $ 314 M canadaCanada
Incyte Corporation Incyte Corporation
INCY
 		66.6 $ 97.08 1.55 % $ 19 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		216 - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		13.6 - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		126 - - $ 26.5 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		28.1 $ 3.39 4.17 % $ 5.58 M israelIsrael
AIkido Pharma AIkido Pharma
AIKI
 		17.9 - 1.93 % $ 17.4 M usaUSA
Aptinyx Aptinyx
APTX
 		46.9 - -39.0 % $ 4.57 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
 		559 $ 1.51 2.03 % $ 177 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		14.7 - -0.23 % $ 916 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		106 $ 20.47 4.97 % $ 2.6 B usaUSA